GlassScriptPhysician profile
Nelly Molano
NPI 1215987318
$1,146.48
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.34 · 2022: $214 · 2023: $623 · 2024: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $193.60 | 2022-2024 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $170.13 | 2023 | Veozah |
| Lilly USA, LLC | $141.05 | 2021-2024 | Mounjaro, Emgality, Jardiance |
| Amgen INC. | $109.50 | 2022-2023 | Repatha, Otezla, Evenity |
| Mylan Specialty L.P. | $96.58 | 2023-2024 | Yupelri |
| Xeris Pharmaceuticals, INC. | $81.55 | 2024 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $72.40 | 2022-2024 | Breztri, Farxiga |
| Abbvie INC. | $57.27 | 2023 | |
| Pfizer INC. | $40.36 | 2023 | |
| Glaxosmithkline, LLC. | $23.67 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.29 | 2023 | Jardiance |
| Amarin Pharma, INC. | $19.65 | 2022 | |
| Exact Sciences Corporation | $19.33 | 2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $19.01 | 2021 | |
| Abbott Laboratories | $17.91 | 2023 | Freestyle Libre 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $17.14 | 2023 | Loreev Xr |
| Phathom Pharmaceuticals, INC. | $17.10 | 2024 | Voquezna |
| Medtronic, INC. | $16.43 | 2024 | Closurefast |
| Takeda Pharmaceuticals U.S.A., INC. | $13.51 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelly Molano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.